NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000037795

Registered date:17/09/2019

The study of the effect of frequent measurement of glycoalbumin

Basic Information

Public titleThe study of the effect of frequent measurement of glycoalbumin
Scientific titleThe study of the effect of frequent measurement of glycoalbumin
Recruitment statusComplete: follow-up continuing
Health condition(s) or Problem(s) studiedType 2 diabetes
Study typeInterventional
Phase
Study design
Intervention(s)Frequent measurement of glycoalbumin levels and participants know the result on the same day Frequent measurement of glycoalbumin levels and participants know the result on the last day
Sample Size80
Date of first enrollment2019/09/17
Completion date01/07/2024
Countries of recruitmentJapan

Outcome(s)

Primary OutcomeHbA1c levels, glycoalbumin levels, fasting glucose levels
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaParticipants who use insulin and GLP-1 Participants positive for HIV, hepatitis C, syphilis Participants determined to be difficult to continue the study by doctors

Related Information

Primary SponsorThe University of Tokyo Hospital
Secondary
Source(s)AMED

Secondary Identifiers

Secondary ID

Contact

public contact
Name Aihara Masakazu AIHARA
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo Japan 113-8655
Telephone 81-3-5800-8818
E-mail maihara-tky@umin.ac.jp
Affiliation The University of Tokyo Hospital Department of Diabetes and Metabolic Diseases
scientific contact
Name Kubota Naoto
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo Japan
Telephone 81-3-5800-8818
E-mail nkubota-tky@umin.ac.jp
Affiliation The University of Tokyo Hospital Department of Diabetes and Metabolic Diseases

Ethics Reviews

StatusYES
Approval Date30/07/2019
Contact NameThe University of Tokyo Hospital
Contact Address7-3-1 Hongo, Bunkyo-ku, Tokyo
Contact Phone03-5841-3600
Contact Emailethics@m.u-tokyo.ac.jp

Summary Results

Date of posting of results summaries
Date of the first journal publication of results
URL hyperlink(s) related to results and publications
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Brief Summary
URL link to protocol file(s) with version and date

IPD sharing statement

Plan to share IPD
Plan description